Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rosbank closed two thirds of its branches

10/8/24 TCSG

Last day of trading in Globaltrans receipts on the Moscow Exchange will be October 18

10/8/24 GLTR

Mosgorlombard develops its own resale-platform

10/8/24 MGKL

Bank of Russia unfroze additional share issue of Positive Technologies

10/8/24 POSI

Rusal shareholders argue about buyback

10/8/24 RUAL

Globaltrans started buying back receipts

10/8/24 GLTR

Globaltrans filed applications for delisting from the Moscow Exchange

10/7/24 GLTR

Novabev Group shipments for 9 months decreased by 3%

10/7/24 BELU

Severstal's investment in pellet production in Cherepovets will grow to ₽116 billion

10/7/24 CHMF

Globaltrans shareholders approved the repurchase of depositary receipts

10/7/24 GLTR